T H E    G O L D E N    S T A T E   

BioBUSINESS NEWS
B I O M E D I C A L    B U S I N E S S    N E W S L E T T E R    S I N C E    1 9 8 7

  Contents  
 

Contents



Here is the Table of Contents from selected issues of The Golden State BioBusiness News™.
 
July/August 2007
  • Spotlight Company - Favrille, Inc., a San Diego company developing perosonalized immunotherapy for lymphoma; we interview Dr. John P. Longenecker, CEO 
  • Focus on Science - Immunotherapy for NHL by Frank H. Eeckman, MD, PhD, Science Editor 
  • Money Talks - Convertible Debt: A Creative Financing Option by Steven J. Stuckey, Comerica Bank 
  • Risk Management - Risk Management for the Entrepreneur: A Primer by Dave Hock, ABD Insurance and Financial Services 
  • Opinion - Food and Drug Safety: Who is Really Responsible, by Greg B. Scott, Managing Editor 
  • Deal Diary - Amgen buys Ilypsa; Arete, Jazz, Stratagent, and others
  • Company News - Ablation, Anacor, Medivation Nventa, and more 
  • Events Calendar - upcoming California and China biomedical investment conferences
June 2007
  • Spotlight Company - Artielle ImmunoTherapeutics, Tigard, OR, is developing drugs for multiple sclerosis and other diseases 
  • Focus on Science - Autoimmune Disease by Frank H. Eeckman, MD, PhD, Science Editor 
  • Money Talks - New Vehicles for Biotech: Blurring the Line Between Private and Public Funding, by Roger S. Flugel, PhD, Principal, Sanderling Ventures 
  • Real Estate - An Efficient, Not Cheap, Real Estate Spend, by Matthew DeBellis, BioMed Realty Trust, Inc. 
  • Opinion - Could War with China be Imminent? by Greg B. Scott, Managing Editor 
  • Deal Diary - Orexigen, Victory Pharma, SciClone and others
  • Company News - InSite, Oculus, Ingenuity and more 
  • Events Calendar - upcoming California and China biomedical investment conferences
May 2007
  • Spotlight Company - CODA Genomics, Inc., a Laguna Hills company, designs synthetic genes that express better proteins
  • Focus on Science - The Protein Production Challenge by Frank H. Eeckman, MD, PhD, Science Editor 
  • Money Talks - How a Venture Capitalist Views Your Business Model by John J. Taylor, Vice President, FairView Advisors, LLC 
  • Risk Management - Informed  Consent as Risk Management by Laura Sunderline, Ace Medical Risk and Cristina Varner, ABD Insurance 
  • Opinion - Is Virtual Now the Real Reality? by Killu Sanborn, PhD, SVP, Comerica Bank 
  • Deal Diary - CardioNet, Ascenta, VasoNova and others
  • Company News - Janus, Abaxis, Cardica and more 
  • Events Calendar - upcoming California and China biomedical investment conferences
April 2007
  • Spotlight Company - Naviscan PET Systems, Inc., a San Diego device company
  • Focus on Science - Breast Cancer by Frank H. Eeckman, MD, PhD, Science Editor
  • Money Talks - Option Pricing Theory and its Relationship to Stakeholder Motivations by Steven J. Stuckey, SVP of Comerica Bank 
  • Legal Tips - Partnering with Big Pharma: How to Structure a Successful Agreement by Glen Sato, Partner, Cooley Godward Kronish LLP and Greg B. Scott, Managing Editor 
  • Deal Diary - Phenomix, VentiRx, Trius, Visiogen and others
  • Company News - Map Pharma, Bridgetech, Gen-Probe, eGene and more
  • Events Calendar - upcoming California biomedical investment conferences
February 2007
  • Spotlight on CardioNet, Inc. - Interview with Jim Sweeney, CEO of this San Diego-based real-time outpatient cardiac monitoring company
  • Focus on Science - Cardiac Arrhythmias by Frank H. Eeckman, MD, PhD Science Editor
  • Opinion Will Biotech IPOs Bounce Back in 2007? by Greg Scott, Managing Editor 
  • Money Talks How Much is Your Company Worth? by John J. Taylor, VP, FairView Advisors 
  • Risk Management Biomedical Employers Can Substantially Reduce Employee Benefits Costs by Dennis Rainey, VP, ABD Insurance and Financial Services 
  • Deal Diary Money Finds Home in California Biomedical Ventures by Richard Daverman, PhD, Business Editor
  • Company News - updates on Exelixis, BioMarin, N Spine and others
  • Events Calendar - upcoming California biomedical investment conferences
January 2007
  • Spotlight on N Spine, Inc. - Interview with Sean Na, CEO of this San Diego-based spine implant company focused on dynamic stabilization 
  • Focus on Science - Dynamic Stabilization by Frank H. Eeckman, MD, PhD Science Editor
  • Opinion Does it Pay to be an Entrepreneur in Today's Climate? by Killu Sanborn, SVP, Comerica Bank 
  • Money Talks How Much is Your Company Worth? by John J. Taylor, VP, FairView Advisors 
  • Special Report China Generates New Opportunities for California Biomendical Companies by Greg Scott, CEO, Centient Consulting 
  • Deal Diary California Biomedical Companies Raise as much as $100 Million by Richard Daverman, PhD, Business Editor
  • Company News - updates on Dynavax, VistaGen, Bionovo, Janus and others
  • Events Calendar - upcoming biomedical investment conferences
November/December 2006
  • Spotlight on Triage Wireless - Interview with Tom Watlington, CEO, and Dr. Matthew Banet, President and CTO; Triage is developing a novel wireless, cuffless continuous blood pressure monitor
  • Focus on Science - Focus on Hypertension by Frank H. Eeckman, MD, PhD Science Editor
  • Opinion The Dilemma of Negative Trial Results by Frank H. Eeckman, MD, PhD Science Editor
  • Money Talks Formulas for Financing Success in Early Stage Biomedical Ventures by Peter C.M. McWilliams, Principal, Sanderling Ventures
  • Real Estate Non-Dilutive Funding May Be at Your Front Door by Rick Bell for BioMed Realty Trust, Inc.
  • Deal Diary Previous Spotlight Company Althenagen Raises $50 Million by Richard Daverman, PhD, Business Editor
  • Company News - updates on N Spine, Plexxikon, Alsius, Cytori, Jazz, CellGate, Amgen and others
  • Events Calendar - upcoming biomedical investment conferences
  • Bonus Features - more in-depth information on hypertension (see Bonus)
October 2006
  • Spotlight on Athenagen, Inc. - Interview with Dr. Scott Harkenon, President and CEO of this angiogenesis company utilizing technology out of Stanford
  • Focus on Science - Focus on Angiogenesis by Frank H. Eeckman, MD, PhD Science Editor
  • Opinion Where Has All the Funding Gone? by Greg B. Scott, Managing Editor
  • Money Talks Stretching Your Investment Dollars by Killu Sanborn, SVP, Comerica Bank 
  • Risk Management Managing Biotechnology Risk from Concept to Commercialization by Richard Lane, President ABD Northwest, Peter Daily, SVP, ABD Insurance and Financial Services 
  • Deal Diary A Classic VC Tale - Spinout, Merger and $60 Million by Richard Daverman, PhD, Business Editor
  • Company News - updates on Xtent, Exelixis, Codexis, ICU Medical, Thermage, Guava and others
  • Events Calendar - upcoming biomedical investment conferences
  • Bonus Features - podcast of the interview with Dr. Harkonen (see Bonus)
September 2006
  • Spotlight on Novocell Inc. - Interview with Dr. Alan Lewis, President and CEO of this stem cell company 
  • Focus on Science - Stem Cells to Treat Diabetes by Frank H. Eeckman, MD, PhD Science Editor
  • Opinion - Stem Cells: Much Promise, Many Hurdles by Greg B. Scott, Managing Editor
  • Money Talks - Why Use an Investment Banker to Sell Your Company? by John J. Taylor, VP, FairView Advisors LLC
  • Legal Tips - How to Set a Patent Strategy by Cooley Godward LLP
  • Deal Diary - VC Activity on the Rise in California by Richard Daverman, PhD, Business Editor
  • Company News - updates on Alphatec, Avera, Receptor BioLogix, Gilead, Aradigm and others
  • Events Calendar - upcoming biomedical investment conferences
  • Bonus Features - podcast of the interview with Dr. Lewis, indepth look at Novocell's science (see Bonus)
 
Last Updated: Aug 19, 2006 at 2:30 PM



 
     
© Copyright 2007 Golden Triangle Productions. All Rights Reserved.